The 52 kDa transformation-sensitive protein p52 was previously identified as a major substrate-associated component of normal rat kidney (NRK) fibroblasts [Higgins & Ryan (1989) Biochem. J. 257, 173-182]. p52 selectively localized to cellular fractions enriched in substrate focal-contact sites and associated ventral undersurface elements. Rapid attachment/spreading of NRK cells on to prepared p52 matrices and inhibition of fibroblast spreading by antibodies to p52 indicated that this protein participates in shape determination or cell-to-substrate adhesion. NRK cells transformed with Kirsten murine sarcoma virus (KiMSV), with a temperature-sensitive mutant (ts-371 KiMSV) and maintained at the permissive temperature, or with the cloned EJrasval-12 oncogene, exhibited down-regulated accumulation of p52 in the ventral undersurface region. Immunochemical, lectin-affinity and electrophoretic analyses indicated that p52 shares considerable sequence similarity with plasminogen-activator inhibitor type-1, which is consistent with its subcellular localization and likely morphoregulatory activity. The marked down-regulation of p52 expression seen in four different ras-mediated transformation systems, its induction prior to butyrate-induced morphological reorganization in KiMSVtransformed cells, and the morphological consequences of exogenously added p52 or p52 antibodies on NRK fibroblasts suggest that this protein probably functions in cell-shape regulation. Abrogation of p52 matrix accumulation typically seen in ras transformants may contribute, therefore, to the aberrant cytoarchitecture characteristic of malignant fibroblasts.
INTRODUCTION
Cell-to-substrate adhesion is usually altered in fibroblasts expressing mutant ras oncogenes. v-K-ras-transformed rat kidney (KNRK) cells, for example, exhibit several anomalies in substratum-attachment elements. These include loss of cellassociated laminin, failure to assemble a fibronectin (FN)-rich extracellular matrix (ECM) (Hayman et al., 1981) , reduced integrin content (including one FN receptor) (Plantefaber & Hynes, 1989) , disruption of actin microfilaments (MFs) and associated focal-contact (FC) structures (Altenburg et al., 1976; Ryan & Higgins, 1988) , decreased ventral undersurface deposition of the 52 kDa glycoprotein p52 and reduced ECM adherence (Hynes, 1976; Yamada, 1983; Sistonen et al., 1987) . Integrins link ECM components to the cytoskeleton, probably through the MF-associated proteins vinculin and talin (Damsky et al., 1985; Chen et al., 1986) .
Deficient integrin content, distribution or receptor activity might therefore contribute to the altered morphology, reduced adhesion and cytoskeletal (CSK) anomalies typical of ras-transformants (Plantefaber & Hynes, 1989) . Cell adhesion, however, is a complex process involving at least 30 distinct protein species (Edelman, 1988) . Understanding cell-shape regulation requires further study of the activities and interactions within this diverse protein group.
Normal rat kidney (NRK) fibroblast p52 localizes to cellular fractions enriched in substrate-anchoring elements . Morphologically abnormal KNRK cells fail to express p52 constitutively, but are inducible for p52 synthesis and substrate deposition upon exposure to sodium N-butyrate (NaB) . Pulse-chase studies indicated that the saponin-resistant ECM (consisting of FCs and the ventral undersurface 'carpet') is the initial site of p52 targeting . ECM deposition of p52 occurred before NaB-induced increases in KNRK-cell flattening (Altenburg et al., 1976; . Plating of KNRK fibroblasts on to prepared p52-enriched matrices, moreover, resulted in rapid spreading similar to the temporary morphological reversions induced by FN (Ali et al., 1977; Wagner et al., 1981) . These data stimulated additional analysis of p52 expression in normal and ras-transformed fibroblasts, including a comparison with proteins implicated in cell-shape regulation.
MATERIALS AND METHODS
Cell culture NRK, KNRK (Ryan & Higgins, 1988 , 1989 Vol. 273 the transformingp21V-K-ra8 gene) (Shih et al., 1979) were grown in RPMI 1640 medium with 10 % (v/v) fetal-bovine serum (FBS). Porcine aorta endothelial (PE) and bovine pulmonary-artery endothelial (CPAE) cells (A.T.C.C., CCL-209) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with100% FBS, non-essential amino acids, heparin (0.1 mg/ ml; 166 units/mg), endothelial-cell growth factor (ECGF; 0.1 mg/ml; Meloy Laboratories, Springfield, VA, U.S.A.) (Phillips et al., 1988; White et al., 1990 ,ug/ml respectively to cultures 24 h before metabolic labelling .
Treatment of KNRK-cell cultures with NaB (2 mm final concn.) was as detailed by and . Transfection NRK cells were seeded into DMEM+10%-FBS medium. DNA plasmids pWLneo and pEJ6.6, encoding the neomycin/ G418-resistance and activated human EJrasval 12 genes, were combined (total DNA 20-30 /tg) in 500 41 of 250 mM-CaCl2, diluted with 500 ,1 of 2 x BBS [50 mM-Bes (pH 6.95)/280 mMNaCl/ 1.5 mM-Na2HPO04, left for 20 min, then added to cell cultures (Chen & Okayama, 1987) . Media were changed after 24 h and cells passaged on day 7 to 100 mm-diameter dishes containing RPMI 1640 + 10 % FBS medium. G418 (300 /tg/ml) was added 6 days later, and colonies of morphologically distinct cell types were isolated with cloning cylinders after 2 weeks of G418 selection.
Metabolic labelling, cell extraction and gel electrophoresis Cells were labelled with [35S]methionine as described by Ryan & Higgins (1988) . Labelling media containing secreted proteins (SP) were aspirated and clarified at 13000 g. Cells were washed with Ca2+/Mg2+-free phosphate-buffered saline (0.01M-sodium phosphate/0.14M-NaCI) (CMF-PBS), pH 7.1, then incubated at 25°C in 0.2% (w/v) saponin/CMF-PBS for 20 min and dislodged with a stream of CMF-PBS (Neyfakh & Svitkina, 1983) . The substrate-attached residue (SAP fraction) was scraped into one-dimensional-electrophoresis sample buffer (ESB) [50 mM-Tris/HCI (pH 6.8)/10% glycerol/l % SDS/l % 2-mercaptoethanol] and boiled or solubilized in two-dimensional buffer [9.8 M urea/2 % Nonidet P40 (NP40)/2 % (v/v) pH 7-9 ampholytes/100 mM-dithiothreitoll. Electrophoresis of 2.4 x 104-5.0 x 105 c.p.m. trichloroacetic acid-insoluble SAP residue protein was as described by and . Fluorographs of En3Hance (New England Nuclear)-treated gels were densitometrically scanned and the SAP-fraction protein-p52 content quantified with a Zeiss MOP III digital image analyser . After1 h at 37°C the medium was aspirated and the cells then fixed in methanol and stained. The percentage of well-spread fibroblasts was quantified as described above.
Characterization of the SP fraction
[35]methionine-labelled SP were fractionated according to differential solubility in (NH4)2S04 and affinity for concanavalin A (Con A)-Sepharose 4B beads (Sigma) (Canfield et al., 1987) . (NH4) Table 1 and Fig. 3 . Very flat cl-13 and 2A cells accumulated significantly more SAP-fraction p52 than parental NRK fibroblasts. By comparison, the progressively abnormal EJras isolates cl-R3 and R2 were deficient in SAP-fraction p52 content (Fig. 4) .
Characterization/properties of p52 and p52-like proteins NRK cell spreading reflected SAP-fraction p52 content (Figs. 1-4), suggesting that p52 might function in cell-to-substrate adhesion. Indeed, plating of NRK cells directly on to p52-enriched matrices resulted in enhanced cell flattening compared with matrices prepared with an equivalent amount of FBS protein (in both cases, assays were carried out in a > 250-fold excess of FBS protein). SAP-fraction protein promoted cell spreading even more effectively when added directly to the medium immediately before seeding of cells (Table 2) . Although SAP fractions consist predominantly of p52 (see the Materials and methods section), there was the possibility that a minor component of such preparations was the active mediator of cell (1989, 1990 (Fig. 5) .
On the basis of relative abundance (approx. 20 % of total SP), core size of 43000 Mr, two-dimensional-electrophoretic microheterogeneity and ECM association, p52 appeared similar to Gp47 (Canfield et al., 1987 (Canfield et al., , 1989 ) and p45 (White et al., 1990) of bovine retinal and porcine/bovine arterial endothelial cells respectively (Fig. 6) respectively, relative to actin (Fig. 6) . CPAE SAP fractions, in contrast, had a relatively low p45CPA./actin ratio. Since Gp47 is identical with plasminogen-activator inhibitor type-I (PAI-1) (Canfield et al., 1989) , the biochemical/immunochemical properties of p52 were compared with those of Gp47/PAI-I and related proteins, including human PAI-I and the 52 kDa protein induced in KNRK cells by NaB. Like Gp47, the majority (> 90 %) of p52 was insoluble in 30-70 % satd. (NH4)2SO4 and could be bound by Con A-Sepharose [as was the 50 kDa human mesothelial PAI-I protein ('mesosecrin')] (Rheinwald et al., 1987; Cicila et al., 1989) (Figs. 7a and 7b) . p52 (and human mesothelial PAI-1) also reacted with the same antibody to bovine PAI-I which immunoprecipitated Gp47 (Canfield et al., 1989) , with antibodies to purified human PAI-1, as well as with antibodies to rat PAI-I [Figs. 7b and 7c; see also Higgins et al., (1990) ]. Consistent with previous two-dimensional electrophoretic data , p52 was undetectable in the SP of KNRK cells by metabolic labelling, IP or Con A binding (Figs. 7c and 7d) . Both p52 and its lessglycosylated isoform, p50, however, were readily detected by all three methods in the SP of KNRK/NaB cells (Figs. 7c and 7d) . By using these criteria, therefore, NaB-induced p52 in KNRK cells was indistinguishable from p52 constitutively expressed by NRK fibroblasts. NRK p52, the PAI-i-like p45 protein of PE cells (Fig. 8) and the 50 kDa PAI-I from human mesothelial (Fig. 7) Using NRK/CD SP as source of p52, both p52 and its less-glycosylated isoform p50 were immunoprecipitated (IP) by antibodies to rat PAI-l (rPAl-i) and bound by Con A; substituting normal rabbit serum (NRS) for anti-rPAI-l antibodies failed to precipitate p52. Similarly, the 50 kDa secreted PAI-of human mesothelial cells was also precipitated by antibodies to rPAI-1, by antibodies to human PAl-I (hPAI-l) ( 'oL p45 electrophoretic mobility (Laiho et al., 1987) . p52 was undetectable, however, in the SP or ECM of KNRK cells by electrophoretic mapping by IP (Fig. 7 ) or by treatment with agents known to dissociate protein-protein complexes involving PA-PAI-i (Fig. 9) . DISCUSSION Down-modulation of p52 occurred in four different rasmediated transformation systems. Reduced SAP fraction p52 accumulation is thus neither unique to retrovirus-transformed cells nor an artifact of long-term culture. p52 down-regulation was linked to morphological transformation and, for the most aberrant NRK EJrasva ' 2-transfectants, approached the low level characteristic of KNRK cells. The present data extend previous observations as to the potential role of p52 in cell spreading and confirm, on the basis of immunochemical and lectin-affinity characteristics, the identity of the NaB-induced 52 kDa protein in KNRK cells as p52. The marked cell spreading associated with NaB exposure, therefore, may be mediated (in large part) by induced p52.
Rat p52, the 47 kDa protein of BHK (Aplin et al., 1981 ) and mouse-embryo (Neyfakh & Svitkina, 1983) fibroblasts, the 43 kDa (Norris, 1989) , FC-1 (Oesch & Birchmeier, 1982) , and pSl proteins (Neyfakh & Svitkina, 1983 ) of chick-embryo fibroblasts (CEF) cells and human PAI-i (Pollanen et al., 1987; Rheinwald et al., 1987) all localize to the cellular undersurface or ECM. Antibodies to each of these proteins inhibit cell-tosubstrate adhesion, subsequent cell spreading or promote detachment of adherent cells (Oesch & Birchmeier, 1982; Rheinwald et al., 1987; Norris, 1989) . PAI-i binds to vitronectin at the ECM (Declerck et al., 1988) . This interaction may regulate the stability and/or presentation of PAI-I to target pericellular proteolytic elements (Levin & Santell, 1987) . Adhesive inhibition by immune IgG may result from blocking ECM-binding sites on the p52 (PAI-1) molecule or by direct interference with PAI activity. Alternatively, since p52, p45 and mesosecrin have CSKprotein-like solubility properties (Rheinwald et al., 1987; Santaren & Bravo, 1987; , they may function as structural elements in cell-to-substrate adhesion.
Factors contributing to control of local proteolysis relate to the target cell, its stage of differentiation/transformation, the combination of growth factors used (Dano et al., 1985; Laiho et al., 1987; Thalacker & Nilsen-Hamilton, 1987; Laiho & KeskiOja, 1989) , and the spatial distribution and time course of change of each component involved in the response (e.g., ECM constituents, proteinases and their inhibitors) (Mayer et al., 1988) . Distinct ultrastructural localizations of PA and PAI-I occur in cultured cells. Urokinase PA is abundant at FCs, whereas PAI-I and PAI-I-like proteins, including p52, distribute throughout the ventral undersurface (Pollanen et al., 1987 (Pollanen et al., , 1988 Regulation of the PAI-I gene in a given cell type is a complex event involving processing of multiple signals. Indeed, decreased PAI-I secretion in rat cells occurs upon transformation with oncogenes which possess different mechanisms of action; these include v-src (membrane tyrosine kinase), v-myc (nuclear factor), and ras (GTP binding) (Cohen et al., 1989; . The rat PAI-I gene contains multiple 5' flanking region fos-jun/AP-I binding sites (from -592 to -2112 bases upstream of the coding start site) (Bruzdzinski et al, 1990 ). Tandem arrays of AP-1 (activator protein 1) sites initiate both positive and negative transcriptional signals (Curran & Franza, 1988) . The sequence recognized by nuclear factor PEBP1, which is in consensus with AP-l (Satake et al., 1989) , is stimulated by a transiently expressed ras oncogene (Imler et al., 1988) . In cells constitutively expressing high levels of ras, e.g. KNRK, however, PEBP1 responsiveness is lost (probably due to altered PEBP1 phosphorylation), leading to an inability to interact with its recognition sequence (Satake et al., 1989) . The rat PAI-I gene additionally contains multiple recognition sites for non-AP-I (i.e. glucocorticoid) transcriptional effectors (Bruzdzinski et al., 1990) . Such sequences may also be negatively regulated as a function of ras transformation (Jaggi et al., 1988) . It remains to be determined whether AP-l/glucocorticoid response elements effectively regulate p52 (PAI-1) expression in the NRK cell system via ras-linked signal-transduction pathways.
